| ||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
Search results for: "N"
Results 21 - 30 of 276 shown below 
|
||||||||
|
||||||||
|
||||||||
|
||||||||
| NADH oxidase M M Alonso, I Encío, V Martínez-Merino, M Gil and M Migliaccio New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells doi:10.1054/bjoc.2001.2083 Abstract | Full article | PDF |
||||||||
| NADPH cytochrome P450 reductase D Kostrzewa-Nowak, M J I Paine, C R Wolf and J Tarasiuk The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines advance online publication, 2005-06-07 00:00:00.000; doi:10.1038/sj.bjc.6602639 Abstract | Full article | PDF |
||||||||
| NADPH:cytochrome P450 reductase E C Chinje, A V Patterson, M P Saunders, S D Lockyer, A L Harris and I J Stratford Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines? doi:10.1038/sj.bjc.6690819 Abstract | Full article | PDF |
||||||||
| napsin T Ueno, S Linder and G Elmberger Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma doi:10.1038/sj.bjc.6600879 Abstract | Full article | PDF |
||||||||
| NASBA S A Burchill, L Perebolte, C Johnston, B Top and P Selby Comparison of the RNA-amplification based methods RT-PCR and NASBA for the detection of circulating tumour cells doi:10.1038/sj.bjc.6600014 Abstract | Full article | PDF |
||||||||
| nasopharyngeal cancer S P Hu, N E Day, D R Li, R N Luben, K L Cai, T Ou-Yang, B Li, X Z Lu and B A J Ponder Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese advance online publication, 2005-02-22 00:00:00.000; doi:10.1038/sj.bjc.6602347 Abstract | Full article | PDF A Jayasurya, B H Bay, W M Yap and N G Tan Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma doi:10.1054/bjoc.1999.1063 Abstract | Full article | PDF |
||||||||
| nasopharyngeal carcinoma S-B Tan, D Machin, B-C Tai, K-F Foo and E-H Tan A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer doi:10.1038/sj.bjc.6600199 Abstract | Full article | PDF J-C Lin, J-S Jan, C-Y Hsu, R-S Jiang and W-Y Wang Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates doi:10.1038/sj.bjc.6600716 Abstract | Full article | PDF M Agulnik and L L Siu State-of-the-art management of nasopharyngeal carcinoma: current and future directions advance online publication, 2005-03-01 00:00:00.000; doi:10.1038/sj.bjc.6602449 Abstract | Full article | PDF C-K Toh, D Heng, Y-K Ong, S-S Leong, J Wee and E-H Tan Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma advance online publication, 2005-04-05 00:00:00.000; doi:10.1038/sj.bjc.6602525 Abstract | Full article | PDF K-M Lau, S H Cheng, K W Lo, S A K W Lee, J K S Woo, C A van Hasselt, S P Lee, A B Rickinson and M H L Ng Increase in circulating Foxp3+CD4+CD25high regulatory T cells in nasopharyngeal carcinoma patients advance online publication, 2007-01-30 00:00:00.000; doi:10.1038/sj.bjc.6603580 Abstract | Full article | PDF R L Hong, T S Sheen, J Y Ko, M M Hsu, C C Wang and L L Ting Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study doi:10.1038/sj.bjc.6690627 Abstract | Full article | PDF G L Wang, K W Lo, K S Tsang, N Y F Chung, Y S Tsang, S T Cheung, J C K Lee and D P Huang Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma doi:10.1038/sj.bjc.6690818 Abstract | Full article | PDF J T-C Chang, C-T Liao, S-M Jung, T-C V Wang, L-C See and A-J Cheng Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues doi:10.1054/bjoc.2000.1194 Abstract | Full article | PDF M Benasso, G Sanguineti, M D'Amico, R Corvò, I Ricci, G Numico, D Guarneri, V Vitale, E Pallestrini, A Santelli and R Rosso Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma doi:10.1054/bjoc.2000.1485 Abstract | Full article | PDF J-W Lee, C-L Chen, B-T Juang, J-Y Chen, C-S Yang and S-L Doong Elevated expression of thyroid hormone receptor  2 (c-erb A- 2) in nasopharyngeal carcinoma*
doi:10.1054/bjoc.2000.1505 Abstract | Full article | PDF |
||||||||
| nasopharyngeal carcinoma (NPC) J-R Hsiao, Y-T Jin, S-T Tsai, A-L Shiau, C-L Wu and W-C Su Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis doi:10.1038/sj.bjc.6601003 Abstract | Full article | PDF |
||||||||
| NAT2 J Green, E Banks, A Berrington, S Darby, H Deo and R Newton N -acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction doi:10.1054/bjoc.2000.1265 Abstract | Full article | PDF |
||||||||
| national survey R J Sambrook and D J Girling A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom doi:10.1054/bjoc.2001.1817 Abstract | Full article | PDF |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2008 Cancer Research UK | ||
| |||
| Privacy Policy | |||